$9.72
+0.76 (+8.48%)
Open$9.88
Previous Close$8.96
Day High$10.69
Day Low$9.20
52W High$13.27
52W Low$7.16
Volume—
Avg Volume354.7K
Market Cap274.51M
P/E Ratio76.58
EPS$0.13
SectorN/A
Analyst Ratings
Strong Buy
8 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 163.07M | 147.91M | 144.33M |
| Net Income | 24.36M | 24.75M | 19.03M |
| Profit Margin | 14.9% | 16.7% | 13.2% |
| EBITDA | 37.75M | 29.74M | 33.66M |
| Free Cash Flow | 17.25M | 21.04M | 18.12M |
| Rev Growth | +1.4% | +6.3% | -8.5% |
| Debt/Equity | 0.71 | 0.59 | 0.61 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $2.04 | -5.34% | — | 1.28B |
| PICS | Pics Nv | $9.09 | +7.83% | 4.6 | 1.18B |
| DMII | Drugs Made In America Acquis | $10.19 | +0.00% | 49.9 | 649.10M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.19% | 42.2 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.27 | +0.00% | 41.3 | 586.93M |